Ultragenyx Pharmaceutical

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza.

CEO

Emil D. Kakkis

CEOEmil D. Kakkis

Employees

1,276

Employees1,276

Headquarters

Novato, California

HeadquartersNovato, California

Founded

2010

Founded2010

Employees

1,276

Employees1,276

RARE Key Statistics

Market cap

3.49B

Market cap3.49B

Price-Earnings ratio

-5.09

Price-Earnings ratio-5.09

Dividend yield

—

Dividend yield—

Average volume

797.15K

Average volume797.15K

High today

$43.86

High today$43.86

Low today

$41.07

Low today$41.07

Open price

$43.26

Open price$43.26

Volume

675.35K

Volume675.35K

52 Week high

$54.98

52 Week high$54.98

52 Week low

$31.52

52 Week low$31.52

RARE News

Benzinga 5d

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Mond - Benzinga

Loading... Loading... Shares of Ultragenyx Pharmaceutical Inc. RARE fell sharply during Monday’s session after the company revealed new data from the Phase 1/2...

Analyst ratings

89%

of 19 ratings

Buy

89.5%

Hold

10.5%

Sell